Patent 9205208 was granted and assigned to OptiNose on December, 2015 by the United States Patent and Trademark Office.
A nasal delivery device for and a method of delivering a substance, in particular one of a liquid, as a suspension or solution, or a powder containing a medicament, especially systemic or topical pharmaceuticals, or a vaccine to the nasal airway of a subject.